AbCellera Biologics, Inc. (ABCL)
3.62
-0.12
(-3.21%)
USD |
NASDAQ |
Dec 12, 16:00
3.61
-0.01
(-0.28%)
After-Hours: 20:00
AbCellera Biologics Total Assets (Quarterly): 1.356B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 52.04M |
| Oncolytics Biotech, Inc. | 10.82M |
| Aurinia Pharmaceuticals, Inc. | 527.53M |
| Edesa Biotech, Inc. | 14.80M |
| Lexaria Bioscience Corp. | 4.175M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 222.84M |
| Shareholders Equity (Quarterly) | 964.04M |
| Debt to Equity Ratio | 0.1475 |
| Current Ratio | 10.10 |
| Net Debt Paydown Yield | -0.93% |